Close
Digital Health & Ai Innovation summit 2026
Medica Compamed 2026

New SteriTouch antimicrobial additive proven to reduce SARS-CoV-2 by 93% in 2 hours

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Haemonetics Reconnects with CSL in US...

Haemonetics is set to supply CSL Plasma with its...

Norton Healthcare Launches $30 Million High-Tech...

Norton Healthcare has officially opened a new $30 million...

OSF HealthCare Expands RapidAI Platform Across...

OSF HealthCare is expanding its deployment of advanced stroke...

Radical Materials has launched an antimicrobial additive under its SteriTouch® brand which has demonstrated efficacy of 99.9999% within 3 hours against bacteriophage Phi6 and 93% in 2 hours against SARS-CoV-2, the virus responsible for COVID-19.

The result of many months of development and testing, the new additive is supplied as a liquid and is suitable for most solvent-based applications. Radical is continuing with the development of antiviral additives, specifically for water-based systems and polymers.

“Having tested most active substances, including those based on silver, copper, zinc, silane quats and several organics, we now have a much clearer picture of how each performs in different materials and under different conditions.” said company director Nick Corlett.

“There is no ‘one size fits all’ solution, so our intention is to develop a range of anti-viral additives suitable for most of our customers’ applications. We have taken our time to reach this point, but it is important to us that all products carrying the SteriTouch brand are diligently tested and provide robust performance.”

“The last twelve months have seen a great many new products arrive on the market making excessive and often unsubstantiated claims, but Radical is fortunate to be working with some very committed partner companies, intent on delivering genuinely beneficial products.”

Radical Materials is confident in its ability to improve upon this most recent result: “To date, we have only tested one coating containing the new additive against SARS-CoV-2. The results were good [93% reduction in 2 hours] but given the exceptional performance of the additive against Phi6, we would be most surprised if we can’t achieve even better efficacy against SARS-CoV-2.”

Never miss a healthcare headline

Healthcare moves fast – stay on top of it with our must - read briefings.

  • The top hospital and healthcare stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments transforming global healthcare management

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

MEDICAL FAIR ASIA 2026
MEDICAL FAIR CHINA

Latest stories

Related stories

Haemonetics Reconnects with CSL in US Plasma Collection Deal

Haemonetics is set to supply CSL Plasma with its...

Norton Healthcare Launches $30 Million High-Tech Automated Pharmacy Hub

Norton Healthcare has officially opened a new $30 million...

OSF HealthCare Expands RapidAI Platform Across 18 Hospitals to Speed Stroke Care

OSF HealthCare is expanding its deployment of advanced stroke...

Innovaccer and Mastek Form Strategic Healthcare AI Partnership

Innovaccer and Mastek have announced a strategic healthcare AI...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »